-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Werewolf Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q2 2025.
- Werewolf Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$17.5M, a 7.48% increase year-over-year.
- Werewolf Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$73M, a 25.1% decline year-over-year.
- Werewolf Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$73.6M, a 81.7% decline from 2023.
- Werewolf Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$40.5M, a 27.7% increase from 2022.
- Werewolf Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$56.1M, a 11.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)